MedTrace Logo

Measuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences

NCT05860998 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-05-18

No results posted yet for this study

Summary

The investigators propose a fast and inexpensive procedure to determine the prevalence of the Toxoplasmosis infection (Toxoplasma Gondii) in the general population, using response times in a cognitive task instead of costly medical tests. Therefore, the investigators aim to measure the prevalence of Toxoplasmosis and its socio-economic consequences in the general population.

Conditions

  • Toxoplasmosis
  • Rhd

Interventions

DIAGNOSTIC_TEST

Presence of Toxoplasma gondii IgG Antibodies

Testing for the presence of Toxoplasma gondii IgG Antibodies in participants blood.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2023-07-30
Completion
2023-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05860998 on ClinicalTrials.gov